Clinical Implications of Molecular Biomarkers

My Cancer Genome contains information on the clinical impact of molecular biomarkers in cancer-related genes, proteins, and other biomarker types on the use of anticancer therapies in cancer. This information is derived from FDA labels, NCCN and other professional society guidelines, clinical trials, peer-reviewed publications, and more.

Learn About My Cancer Genome

Molecular Medicine Resources

Targeted Therapies

Types, classification, and naming; FDA approved therapies

Molecular Testing

Biomarkers can be detected using multiple types of tests

Molecular Tumor Board

Molecular tumor board for patients with somatic or germline mutations


Understand terms related to precision medicine